vs
Addus HomeCare Corp（ADUS）とカーディナルヘルス（BTSG）の財務データ比較。上の社名をクリックして会社を切り替えられます
カーディナルヘルスの直近四半期売上が大きい（$3.6B vs $373.1M、Addus HomeCare Corpの約9.5倍）。Addus HomeCare Corpの純利益率が高く（8.0% vs 2.2%、差は5.8%）。Addus HomeCare Corpの前年同期比売上増加率が高い（25.6% vs 16.3%）。カーディナルヘルスの直近四半期フリーキャッシュフローが多い（$193.9M vs $16.1M）。過去8四半期でカーディナルヘルスの売上複合成長率が高い（17.4% vs 15.3%）
Addus HomeCare Corpは米国に本拠を置く在宅ケアサービスプロバイダーで、高齢者、障がい者、慢性疾患患者を主な対象に、介護補助、在宅医療支援、ホスピスケアを提供しています。米国複数州で事業を展開し、公的保険運営元、民間保険会社、個人顧客と提携してニーズに合わせたサービスを届けています。
カーディナルヘルスは米国の多国籍医療サービス企業で、米国企業収益ランキング第15位に位置し、本社をオハイオ州ダブリンに置く。医薬品・医療製品流通で10万拠点以上にサービスを提供するほか、手術着や手袋、流体管理製品などを製造し、最大級の放射性医薬品ネットワークも運営する。
ADUS vs BTSG — 直接比較
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $373.1M | $3.6B |
| 純利益 | $29.8M | $77.1M |
| 粗利率 | 33.1% | 11.6% |
| 営業利益率 | 11.3% | 3.0% |
| 純利益率 | 8.0% | 2.2% |
| 売上前年比 | 25.6% | 16.3% |
| 純利益前年比 | 52.5% | 381.8% |
| EPS（希薄化後） | $1.62 | $0.34 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $373.1M | $3.6B | ||
| Q3 25 | $362.3M | $3.3B | ||
| Q2 25 | $349.4M | $3.1B | ||
| Q1 25 | $337.7M | $2.9B | ||
| Q4 24 | $297.1M | $3.1B | ||
| Q3 24 | $289.8M | $2.9B | ||
| Q2 24 | $286.9M | $2.7B | ||
| Q1 24 | $280.7M | $2.6B |
| Q4 25 | $29.8M | $77.1M | ||
| Q3 25 | $22.8M | $55.8M | ||
| Q2 25 | $22.1M | $28.2M | ||
| Q1 25 | $21.2M | $29.5M | ||
| Q4 24 | $19.5M | $16.0M | ||
| Q3 24 | $20.2M | $-8.2M | ||
| Q2 24 | $18.1M | $19.9M | ||
| Q1 24 | $15.8M | $-45.8M |
| Q4 25 | 33.1% | 11.6% | ||
| Q3 25 | 32.2% | 11.8% | ||
| Q2 25 | 32.6% | 11.9% | ||
| Q1 25 | 31.9% | 11.8% | ||
| Q4 24 | 34.2% | 13.8% | ||
| Q3 24 | 31.8% | 14.0% | ||
| Q2 24 | 32.5% | 14.2% | ||
| Q1 24 | 31.4% | 14.3% |
| Q4 25 | 11.3% | 3.0% | ||
| Q3 25 | 9.1% | 2.6% | ||
| Q2 25 | 9.4% | 1.5% | ||
| Q1 25 | 9.0% | 1.8% | ||
| Q4 24 | 9.1% | 2.6% | ||
| Q3 24 | 9.0% | 2.0% | ||
| Q2 24 | 9.1% | 2.3% | ||
| Q1 24 | 8.4% | 0.3% |
| Q4 25 | 8.0% | 2.2% | ||
| Q3 25 | 6.3% | 1.7% | ||
| Q2 25 | 6.3% | 0.9% | ||
| Q1 25 | 6.3% | 1.0% | ||
| Q4 24 | 6.6% | 0.5% | ||
| Q3 24 | 7.0% | -0.3% | ||
| Q2 24 | 6.3% | 0.7% | ||
| Q1 24 | 5.6% | -1.8% |
| Q4 25 | $1.62 | $0.34 | ||
| Q3 25 | $1.24 | $0.26 | ||
| Q2 25 | $1.20 | $0.13 | ||
| Q1 25 | $1.16 | $0.14 | ||
| Q4 24 | $1.06 | $0.11 | ||
| Q3 24 | $1.10 | $-0.04 | ||
| Q2 24 | $1.10 | $0.10 | ||
| Q1 24 | $0.97 | $-0.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $88.4M |
| 総負債低いほど良い | $121.0M | $2.5B |
| 株主資本純資産 | $1.1B | $1.9B |
| 総資産 | $1.4B | $6.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.11× | 1.34× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $88.4M | ||
| Q3 25 | — | $140.3M | ||
| Q2 25 | — | $70.1M | ||
| Q1 25 | $97.0M | $52.3M | ||
| Q4 24 | $98.9M | $61.3M | ||
| Q3 24 | $222.9M | $36.0M | ||
| Q2 24 | $173.3M | $25.0M | ||
| Q1 24 | $76.7M | $58.0M |
| Q4 25 | $121.0M | $2.5B | ||
| Q3 25 | $150.6M | $2.5B | ||
| Q2 25 | $169.1M | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | $218.4M | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.0B | $1.8B | ||
| Q2 25 | $1.0B | $1.7B | ||
| Q1 25 | $995.4M | $1.7B | ||
| Q4 24 | $970.5M | $1.6B | ||
| Q3 24 | $947.6M | $1.6B | ||
| Q2 24 | $921.7M | $1.6B | ||
| Q1 24 | $725.1M | $1.6B |
| Q4 25 | $1.4B | $6.4B | ||
| Q3 25 | $1.4B | $6.0B | ||
| Q2 25 | $1.4B | $5.9B | ||
| Q1 25 | $1.4B | $5.8B | ||
| Q4 24 | $1.4B | $5.9B | ||
| Q3 24 | $1.2B | $5.8B | ||
| Q2 24 | $1.1B | $5.6B | ||
| Q1 24 | $1.0B | $5.7B |
| Q4 25 | 0.11× | 1.34× | ||
| Q3 25 | 0.14× | 1.38× | ||
| Q2 25 | 0.17× | 1.45× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | 0.23× | 1.58× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | — | 1.64× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $18.8M | $231.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $16.1M | $193.9M |
| FCFマージンFCF / 売上 | 4.3% | 5.5% |
| 設備投資強度設備投資 / 売上 | 0.7% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 0.63× | 3.00× |
| 直近12ヶ月FCF直近4四半期 | $103.8M | $394.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $18.8M | $231.6M | ||
| Q3 25 | $51.3M | $107.9M | ||
| Q2 25 | $22.5M | $49.1M | ||
| Q1 25 | $18.9M | $101.6M | ||
| Q4 24 | $10.4M | $90.6M | ||
| Q3 24 | $48.5M | $27.2M | ||
| Q2 24 | $18.8M | $-15.2M | ||
| Q1 24 | $38.7M | $-78.9M |
| Q4 25 | $16.1M | $193.9M | ||
| Q3 25 | $49.3M | $92.2M | ||
| Q2 25 | $21.3M | $24.7M | ||
| Q1 25 | $17.1M | $84.0M | ||
| Q4 24 | $8.7M | $75.3M | ||
| Q3 24 | $46.6M | $7.2M | ||
| Q2 24 | $17.7M | $-39.0M | ||
| Q1 24 | $37.3M | $-100.7M |
| Q4 25 | 4.3% | 5.5% | ||
| Q3 25 | 13.6% | 2.8% | ||
| Q2 25 | 6.1% | 0.8% | ||
| Q1 25 | 5.1% | 2.9% | ||
| Q4 24 | 2.9% | 2.5% | ||
| Q3 24 | 16.1% | 0.2% | ||
| Q2 24 | 6.2% | -1.4% | ||
| Q1 24 | 13.3% | -3.9% |
| Q4 25 | 0.7% | 1.1% | ||
| Q3 25 | 0.5% | 0.5% | ||
| Q2 25 | 0.4% | 0.8% | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 0.6% | 0.5% | ||
| Q3 24 | 0.7% | 0.7% | ||
| Q2 24 | 0.4% | 0.9% | ||
| Q1 24 | 0.5% | 0.8% |
| Q4 25 | 0.63× | 3.00× | ||
| Q3 25 | 2.24× | 1.93× | ||
| Q2 25 | 1.02× | 1.74× | ||
| Q1 25 | 0.89× | 3.44× | ||
| Q4 24 | 0.53× | 5.66× | ||
| Q3 24 | 2.41× | — | ||
| Q2 24 | 1.04× | -0.76× | ||
| Q1 24 | 2.44× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ADUS
| Personal Care | $286.0M | 77% |
| Hospice | $70.0M | 19% |
| Home Health | $17.1M | 5% |
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
